Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| enGene Holdings Inc. | 3,036,153 | reported | 22 Apr 2024 | tx 3−52,529 |
| Milestone Pharmaceuticals Inc. | 2,254,920 | reported | 29 Jul 2020 | tx 13+2,689,743−2,776,273 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Apr 2024 | SALE | enGene Holdings Inc. | 100 | 15.00 USD | |
| 22 Apr 2024 | SALE | enGene Holdings Inc. | 47,854 | 15.00 USD | |
| 18 Apr 2024 | SALE | enGene Holdings Inc. | 4,575 | 15.01 USD | |
| 29 Jul 2020 | SALE | Milestone Pharmaceuticals Inc. | 500,000 | 8.32 USD | |
| 28 Jul 2020 | SALE | Milestone Pharmaceuticals Inc. | 19,863 | 8.10 USD | |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 139,849 | — | |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 798,974 | — | |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 574,292 | — | |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 306,092 | — | |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 437,203 | — | |
| 13 May 2019 | PURCHASE | Milestone Pharmaceuticals Inc. | 433,333 | 15.00 USD | |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 306,092 | — | deriv |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 437,203 | — | deriv |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 798,974 | — | deriv |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 139,849 | — | deriv |
| 13 May 2019 | CONVERSION | Milestone Pharmaceuticals Inc. | 574,292 | — | deriv |